MYOS RENS Technology Reports Fourth Quarter And Fiscal 2017 Financial Results

CEDAR KNOLLS, N.J., March 27, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and owner of Fortetropin®, a proprietary ingredient that helps build lean muscle in conjunction with resistance training, announced today its...